Prenatal vaccination of mothers and hepatitis B vaccination of their infants

Research output: Contribution to journalArticle

Abstract

Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and influenza vaccination are recommended during pregnancy primarily to prevent influenza and pertussis in mothers and their infants. This study examines associations between prenatal Tdap vaccination and influenza vaccination of mothers and hepatitis B vaccination of their infants. A retrospective cohort study was conducted using data from electronic medical records from 15,468 deliveries to 14,925 mothers occurring April 2, 2014-December 3, 2016 at a university hospital in Texas. Hepatitis B vaccine receipt in the first 3 days of life was dichotomized. Margins post-estimation commands in Stata SE 15.1 were used to obtain predicted probabilities and risk differences after estimating odds ratios in logistic regression with robust variance estimates. Adjusted models included maternal age, race/ethnicity, Medicaid use, year of delivery, parity, and gravidity. Infants of mothers who received prenatal influenza vaccination in the 2014–2015 and 2015–2016 influenza seasons were more likely than those of mothers who did not to receive a hepatitis B vaccine in their first 3 days of life (adjusted risk difference (RD) 2.8%, 95% confidence interval (CI) 1.5–4.1% and RD 2.2%, 95% CI 0.9–3.5%, respectively). Hepatitis B vaccination was also higher among infants of Tdap-eligible mothers who received prenatal Tdap vaccination during pregnancy compared to those of mothers who did not (adjusted RD 9.1%, 95% CI 7.6–10.5%). Overall, prenatal vaccination was significantly associated with uptake of infant hepatitis B vaccine.

Original languageEnglish (US)
Pages (from-to)68-73
Number of pages6
JournalPreventive Medicine
Volume121
DOIs
StatePublished - Apr 1 2019

Fingerprint

Hepatitis B
Vaccination
Mothers
Whooping Cough
Diphtheria
Human Influenza
Tetanus
Hepatitis B Vaccines
Confidence Intervals
Gravidity
Pregnancy
Electronic Health Records
Maternal Age
Medicaid
Parity
Cohort Studies
Retrospective Studies
Logistic Models
Odds Ratio

Keywords

  • Behavior
  • Human influenza
  • Infant
  • Pediatrics
  • Pregnancy
  • Vaccination
  • Whooping cough

ASJC Scopus subject areas

  • Epidemiology
  • Public Health, Environmental and Occupational Health

Cite this

@article{b92794039f1b4c45b38766a7dc14438b,
title = "Prenatal vaccination of mothers and hepatitis B vaccination of their infants",
abstract = "Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and influenza vaccination are recommended during pregnancy primarily to prevent influenza and pertussis in mothers and their infants. This study examines associations between prenatal Tdap vaccination and influenza vaccination of mothers and hepatitis B vaccination of their infants. A retrospective cohort study was conducted using data from electronic medical records from 15,468 deliveries to 14,925 mothers occurring April 2, 2014-December 3, 2016 at a university hospital in Texas. Hepatitis B vaccine receipt in the first 3 days of life was dichotomized. Margins post-estimation commands in Stata SE 15.1 were used to obtain predicted probabilities and risk differences after estimating odds ratios in logistic regression with robust variance estimates. Adjusted models included maternal age, race/ethnicity, Medicaid use, year of delivery, parity, and gravidity. Infants of mothers who received prenatal influenza vaccination in the 2014–2015 and 2015–2016 influenza seasons were more likely than those of mothers who did not to receive a hepatitis B vaccine in their first 3 days of life (adjusted risk difference (RD) 2.8{\%}, 95{\%} confidence interval (CI) 1.5–4.1{\%} and RD 2.2{\%}, 95{\%} CI 0.9–3.5{\%}, respectively). Hepatitis B vaccination was also higher among infants of Tdap-eligible mothers who received prenatal Tdap vaccination during pregnancy compared to those of mothers who did not (adjusted RD 9.1{\%}, 95{\%} CI 7.6–10.5{\%}). Overall, prenatal vaccination was significantly associated with uptake of infant hepatitis B vaccine.",
keywords = "Behavior, Human influenza, Infant, Pediatrics, Pregnancy, Vaccination, Whooping cough",
author = "Erika Fuchs and Jonathan Starkey and Richard Rupp and Abbey Berenson",
year = "2019",
month = "4",
day = "1",
doi = "10.1016/j.ypmed.2019.02.013",
language = "English (US)",
volume = "121",
pages = "68--73",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Prenatal vaccination of mothers and hepatitis B vaccination of their infants

AU - Fuchs, Erika

AU - Starkey, Jonathan

AU - Rupp, Richard

AU - Berenson, Abbey

PY - 2019/4/1

Y1 - 2019/4/1

N2 - Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and influenza vaccination are recommended during pregnancy primarily to prevent influenza and pertussis in mothers and their infants. This study examines associations between prenatal Tdap vaccination and influenza vaccination of mothers and hepatitis B vaccination of their infants. A retrospective cohort study was conducted using data from electronic medical records from 15,468 deliveries to 14,925 mothers occurring April 2, 2014-December 3, 2016 at a university hospital in Texas. Hepatitis B vaccine receipt in the first 3 days of life was dichotomized. Margins post-estimation commands in Stata SE 15.1 were used to obtain predicted probabilities and risk differences after estimating odds ratios in logistic regression with robust variance estimates. Adjusted models included maternal age, race/ethnicity, Medicaid use, year of delivery, parity, and gravidity. Infants of mothers who received prenatal influenza vaccination in the 2014–2015 and 2015–2016 influenza seasons were more likely than those of mothers who did not to receive a hepatitis B vaccine in their first 3 days of life (adjusted risk difference (RD) 2.8%, 95% confidence interval (CI) 1.5–4.1% and RD 2.2%, 95% CI 0.9–3.5%, respectively). Hepatitis B vaccination was also higher among infants of Tdap-eligible mothers who received prenatal Tdap vaccination during pregnancy compared to those of mothers who did not (adjusted RD 9.1%, 95% CI 7.6–10.5%). Overall, prenatal vaccination was significantly associated with uptake of infant hepatitis B vaccine.

AB - Tetanus, diphtheria, and acellular pertussis (Tdap) vaccination and influenza vaccination are recommended during pregnancy primarily to prevent influenza and pertussis in mothers and their infants. This study examines associations between prenatal Tdap vaccination and influenza vaccination of mothers and hepatitis B vaccination of their infants. A retrospective cohort study was conducted using data from electronic medical records from 15,468 deliveries to 14,925 mothers occurring April 2, 2014-December 3, 2016 at a university hospital in Texas. Hepatitis B vaccine receipt in the first 3 days of life was dichotomized. Margins post-estimation commands in Stata SE 15.1 were used to obtain predicted probabilities and risk differences after estimating odds ratios in logistic regression with robust variance estimates. Adjusted models included maternal age, race/ethnicity, Medicaid use, year of delivery, parity, and gravidity. Infants of mothers who received prenatal influenza vaccination in the 2014–2015 and 2015–2016 influenza seasons were more likely than those of mothers who did not to receive a hepatitis B vaccine in their first 3 days of life (adjusted risk difference (RD) 2.8%, 95% confidence interval (CI) 1.5–4.1% and RD 2.2%, 95% CI 0.9–3.5%, respectively). Hepatitis B vaccination was also higher among infants of Tdap-eligible mothers who received prenatal Tdap vaccination during pregnancy compared to those of mothers who did not (adjusted RD 9.1%, 95% CI 7.6–10.5%). Overall, prenatal vaccination was significantly associated with uptake of infant hepatitis B vaccine.

KW - Behavior

KW - Human influenza

KW - Infant

KW - Pediatrics

KW - Pregnancy

KW - Vaccination

KW - Whooping cough

UR - http://www.scopus.com/inward/record.url?scp=85061740519&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061740519&partnerID=8YFLogxK

U2 - 10.1016/j.ypmed.2019.02.013

DO - 10.1016/j.ypmed.2019.02.013

M3 - Article

VL - 121

SP - 68

EP - 73

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

ER -